scholarly journals An Effective Method for Detecting and Classifying Diabetic Retinopathy Lesions Based on Deep Learning

2021 ◽  
Vol 2021 ◽  
pp. 1-13
Author(s):  
Abdüssamed Erciyas ◽  
Necaattin Barışçı

Diabetic retinopathy occurs as a result of the harmful effects of diabetes on the eyes. Diabetic retinopathy is also a disease that should be diagnosed early. If not treated early, vision loss may occur. It is estimated that one third of more than half a million diabetic patients will have diabetic retinopathy by the 22nd century. Many effective methods have been proposed for disease detection with deep learning. In this study, unlike other studies, a deep learning-based method has been proposed in which diabetic retinopathy lesions are detected automatically and independently of datasets, and the detected lesions are classified. In the first stage of the proposed method, a data pool is created by collecting diabetic retinopathy data from different datasets. With Faster RCNN, lesions are detected, and the region of interests are marked. The images obtained in the second stage are classified using the transfer learning and attention mechanism. The method tested in Kaggle and MESSIDOR datasets reached 99.1% and 100% ACC and 99.9% and 100% AUC, respectively. When the obtained results are compared with other results in the literature, it is seen that more successful results are obtained.

2020 ◽  
Vol 10 (6) ◽  
pp. 2021 ◽  
Author(s):  
Ibrahem Kandel ◽  
Mauro Castelli

Diabetic retinopathy (DR) is a dangerous eye condition that affects diabetic patients. Without early detection, it can affect the retina and may eventually cause permanent blindness. The early diagnosis of DR is crucial for its treatment. However, the diagnosis of DR is a very difficult process that requires an experienced ophthalmologist. A breakthrough in the field of artificial intelligence called deep learning can help in giving the ophthalmologist a second opinion regarding the classification of the DR by using an autonomous classifier. To accurately train a deep learning model to classify DR, an enormous number of images is required, and this is an important limitation in the DR domain. Transfer learning is a technique that can help in overcoming the scarcity of images. The main idea that is exploited by transfer learning is that a deep learning architecture, previously trained on non-medical images, can be fine-tuned to suit the DR dataset. This paper reviews research papers that focus on DR classification by using transfer learning to present the best existing methods to address this problem. This review can help future researchers to find out existing transfer learning methods to address the DR classification task and to show their differences in terms of performance.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Reza Mirshahi ◽  
Pasha Anvari ◽  
Hamid Riazi-Esfahani ◽  
Mahsa Sardarinia ◽  
Masood Naseripour ◽  
...  

AbstractThe purpose of this study was to introduce a new deep learning (DL) model for segmentation of the fovea avascular zone (FAZ) in en face optical coherence tomography angiography (OCTA) and compare the results with those of the device’s built-in software and manual measurements in healthy subjects and diabetic patients. In this retrospective study, FAZ borders were delineated in the inner retinal slab of 3 × 3 enface OCTA images of 131 eyes of 88 diabetic patients and 32 eyes of 18 healthy subjects. To train a deep convolutional neural network (CNN) model, 126 enface OCTA images (104 eyes with diabetic retinopathy and 22 normal eyes) were used as training/validation dataset. Then, the accuracy of the model was evaluated using a dataset consisting of OCTA images of 10 normal eyes and 27 eyes with diabetic retinopathy. The CNN model was based on Detectron2, an open-source modular object detection library. In addition, automated FAZ measurements were conducted using the device’s built-in commercial software, and manual FAZ delineation was performed using ImageJ software. Bland–Altman analysis was used to show 95% limit of agreement (95% LoA) between different methods. The mean dice similarity coefficient of the DL model was 0.94 ± 0.04 in the testing dataset. There was excellent agreement between automated, DL model and manual measurements of FAZ in healthy subjects (95% LoA of − 0.005 to 0.026 mm2 between automated and manual measurement and 0.000 to 0.009 mm2 between DL and manual FAZ area). In diabetic eyes, the agreement between DL and manual measurements was excellent (95% LoA of − 0.063 to 0.095), however, there was a poor agreement between the automated and manual method (95% LoA of − 0.186 to 0.331). The presence of diabetic macular edema and intraretinal cysts at the fovea were associated with erroneous FAZ measurements by the device’s built-in software. In conclusion, the DL model showed an excellent accuracy in detection of FAZ border in enfaces OCTA images of both diabetic patients and healthy subjects. The DL and manual measurements outperformed the automated measurements of the built-in software.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Donato Santovito ◽  
Lisa Toto ◽  
Velia De Nardis ◽  
Pamela Marcantonio ◽  
Rossella D’Aloisio ◽  
...  

AbstractDiabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of DR depends on prompt treatment and would benefit from biomarkers for screening and pre-symptomatic detection of retinopathy in diabetic patients. MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression which are released in the bloodstream and may serve as biomarkers. Little is known on circulating miRNAs in patients with type 2 diabetes (T2DM) and DR. Here we show that DR is associated with higher circulating miR-25-3p (P = 0.004) and miR-320b (P = 0.011) and lower levels of miR-495-3p (P < 0.001) in a cohort of patients with T2DM with DR (n = 20), compared with diabetic subjects without DR (n = 10) and healthy individuals (n = 10). These associations persisted significant after adjustment for age, gender, and HbA1c. The circulating levels of these miRNAs correlated with severity of the disease and their concomitant evaluation showed high accuracy for identifying DR (AUROC = 0.93; P < 0.001). Gene ontology analysis of validated targets revealed enrichment in pathways such as regulation of metabolic process (P = 1.5 × 10–20), of cell response to stress (P = 1.9 × 10–14), and development of blood vessels (P = 2.7 × 10–14). Pending external validation, we anticipate that these miRNAs may serve as putative disease biomarkers and highlight novel molecular targets for improving care of patients with diabetic retinopathy.


Author(s):  
Mohammad Shorfuzzaman ◽  
M. Shamim Hossain ◽  
Abdulmotaleb El Saddik

Diabetic retinopathy (DR) is one of the most common causes of vision loss in people who have diabetes for a prolonged period. Convolutional neural networks (CNNs) have become increasingly popular for computer-aided DR diagnosis using retinal fundus images. While these CNNs are highly reliable, their lack of sufficient explainability prevents them from being widely used in medical practice. In this article, we propose a novel explainable deep learning ensemble model where weights from different models are fused into a single model to extract salient features from various retinal lesions found on fundus images. The extracted features are then fed to a custom classifier for the final diagnosis of DR severity level. The model is trained on an APTOS dataset containing retinal fundus images of various DR grades using a cyclical learning rates strategy with an automatic learning rate finder for decaying the learning rate to improve model accuracy. We develop an explainability approach by leveraging gradient-weighted class activation mapping and shapely adaptive explanations to highlight the areas of fundus images that are most indicative of different DR stages. This allows ophthalmologists to view our model's decision in a way that they can understand. Evaluation results using three different datasets (APTOS, MESSIDOR, IDRiD) show the effectiveness of our model, achieving superior classification rates with a high degree of precision (0.970), sensitivity (0.980), and AUC (0.978). We believe that the proposed model, which jointly offers state-of-the-art diagnosis performance and explainability, will address the black-box nature of deep CNN models in robust detection of DR grading.


Author(s):  
Sona Sabitha Kumar ◽  
Lathika Vasu Kamaladevi ◽  
Sruthi Mankara Valsan

Background: Diabetes is a major public health concern that affects nearly 463 million (9.3%) of global adult population. Diabetic retinopathy, which affects around 35% of all diabetic patients, is the fifth leading cause of preventable global blindness. This study was done to determine the status of diabetic retinopathy screening and the factors that influence its uptake among diabetic patients attending a tertiary care setting in Kerala, India.Methods: 200 patients with diabetes mellitus on physician care were enrolled for a questionnaire-based survey which collected information on patient demographics, education, occupation, patient’s awareness of retinopathy, screening, diabetic blindness and their source of such knowledge.Results: 83% were aware that diabetes can result in vision loss. 61% were aware that diabetic blindness is preventable. 42% patients were aware of screening options for retinopathy. The awareness of retinopathy screening was significantly associated (p=0.0001) only with duration of diabetes.Conclusions: Awareness of diabetic retinopathy among diabetic patients in Kerala was sub optimal. Better patient education and use of mass media can increase awareness on diabetes retinopathy screening programs. 


Author(s):  
Zhan Wei Lim ◽  
Mong Li Lee ◽  
Wynne Hsu ◽  
Tien Yin Wong

Though deep learning systems have achieved high accuracy in detecting diseases from medical images, few such systems have been deployed in highly automated disease screening settings due to lack of trust in how well these systems can generalize to out-of-datasets. We propose to use uncertainty estimates of the deep learning system’s prediction to know when to accept or to disregard its prediction. We evaluate the effectiveness of using such estimates in a real-life application for the screening of diabetic retinopathy. We also generate visual explanation of the deep learning system to convey the pixels in the image that influences its decision. Together, these reveal the deep learning system’s competency and limits to the human, and in turn the human can know when to trust the deep learning system.


Electronics ◽  
2020 ◽  
Vol 9 (2) ◽  
pp. 274 ◽  
Author(s):  
Thippa Reddy Gadekallu ◽  
Neelu Khare ◽  
Sweta Bhattacharya ◽  
Saurabh Singh ◽  
Praveen Kumar Reddy Maddikunta ◽  
...  

Diabetic Retinopathy is a major cause of vision loss and blindness affecting millions of people across the globe. Although there are established screening methods - fluorescein angiography and optical coherence tomography for detection of the disease but in majority of the cases, the patients remain ignorant and fail to undertake such tests at an appropriate time. The early detection of the disease plays an extremely important role in preventing vision loss which is the consequence of diabetes mellitus remaining untreated among patients for a prolonged time period. Various machine learning and deep learning approaches have been implemented on diabetic retinopathy dataset for classification and prediction of the disease but majority of them have neglected the aspect of data pre-processing and dimensionality reduction, leading to biased results. The dataset used in the present study is a diabetes retinopathy dataset collected from the UCI machine learning repository. At its inceptions, the raw dataset is normalized using the Standardscalar technique and then Principal Component Analysis (PCA) is used to extract the most significant features in the dataset. Further, Firefly algorithm is implemented for dimensionality reduction. This reduced dataset is fed into a Deep Neural Network Model for classification. The results generated from the model is evaluated against the prevalent machine learning models and the results justify the superiority of the proposed model in terms of Accuracy, Precision, Recall, Sensitivity and Specificity.


2020 ◽  
Author(s):  
Nicholas C. Holoman ◽  
Jacob J. Aiello ◽  
Timothy D. Trobenter ◽  
Matthew J. Tarchick ◽  
Michael R. Kozlowski ◽  
...  

AbstractHyperglycemia is a key determinant for development of diabetic retinopathy (DR). Inadequate glycemic control exacerbates retinopathy, while normalization of glucose levels delays its progression. In hyperglycemia, hexokinase is saturated and excess glucose is metabolized to sorbitol by aldose reductase via the polyol pathway. Therapies to reduce retinal polyol accumulation for the prevention of DR have been elusive due to low sorbitol dehydrogenase levels in the retina and inadequate inhibition of aldose reductase. Using systemic and conditional genetic inactivation, we targeted the primary facilitative glucose transporter in the retina, Glut1, as a preventative therapeutic in diabetic male and female mice. Unlike wildtype diabetics, diabetic Glut1+/− mice did not display elevated Glut1 levels in the retina. Furthermore, diabetic Glut1+/− mice exhibited ameliorated ERG defects, inflammation and oxidative stress, which was correlated with a significant reduction in retinal sorbitol accumulation. RPE-specific reduction of Glut1 did not prevent an increase in retinal sorbitol content or early hallmarks of DR. However, like diabetic Glut1+/− mice, reduction of Glut1 specifically in retinal neurons mitigated polyol accumulation and completely prevented retinal dysfunction and the elevation of markers for oxidative stress and inflammation associated with diabetes. These results suggest that modulation of retinal polyol accumulation via Glut1 in photoreceptors can circumvent the difficulties in regulating systemic glucose metabolism and be exploited to prevent DR.SignificanceDiabetic retinopathy (DR) affects one third of diabetic patients and is the primary cause of vision loss in adults aged 20-74. While anti-VEGF and photocoagulation treatments for the late-stage vision threatening complications can prevent vision loss, a significant proportion of patients do not respond to anti-VEGF therapies and mechanisms to stop progression of early-stage symptoms remain elusive. Glut1 is the primary facilitative glucose transporter for the retina. We determined that a moderate reduction in Glut1 levels, specifically in retinal neurons, but not the RPE, was sufficient to prevent retinal polyol accumulation and the earliest functional defects to be identified in the diabetic retina. Our study defines modulation of Glut1 in retinal neurons as a targetable molecule for prevention of DR.


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Silky Goel ◽  
Siddharth Gupta ◽  
Avnish Panwar ◽  
Sunil Kumar ◽  
Madhushi Verma ◽  
...  

Diabetes is a very fast-growing disease in India, with currently more than 72 million patients. Prolonged diabetes (about almost 20 years) can cause serious loss to the tiny blood vessels and neurons in the patient eyes, called diabetic retinopathy (DR). This first causes occlusion and then rapid vision loss. The symptoms of the disease are not very conspicuous in its early stage. The disease is featured by the formation of bloated structures in the retinal area called microaneurysms. Because of negligence, the condition of the eye worsens into the generation of more severe blots and damage to retinal vessels causing complete loss of vision. Early screening and monitoring of DR can reduce the risk of vision loss in patients with high possibilities. But the diabetic retinopathy detection and its classification by a human, is a challenging and error-prone task, because of the complexity of the image captured by color fundus photography. Machine learning algorithms armed with some feature extraction techniques have been employed earlier to detect and classify the levels of DR. However, these techniques provide below-par accuracy. Now, with the advent of deep learning (DL) techniques in computer vision, it has become possible to achieve very high levels of accuracy. DL models are an abstraction of the human brain coupled with the eyes. To create a model from scratch and train it is a cumbersome task requiring a huge amount of images. This deficiency of the DL techniques can be patched up by employing another technique to a task called transfer learning. In this, a DL model is trained on image metadata, and to learn features it used hundreds of classes from the DR fundus images. This enables professionals to create models capable of classifying unseen images into a proper grade or level with acceptable accuracy. This paper proposed a DL model coupled with different classifiers to classify the fundus image into its correct class of severity. We have trained the model on IDRD images and it has proven to show very high accuracy.


Sensors ◽  
2022 ◽  
Vol 22 (2) ◽  
pp. 542
Author(s):  
Muhammad Mateen ◽  
Tauqeer Safdar Malik ◽  
Shaukat Hayat ◽  
Musab Hameed ◽  
Song Sun ◽  
...  

In diabetic retinopathy (DR), the early signs that may lead the eyesight towards complete vision loss are considered as microaneurysms (MAs). The shape of these MAs is almost circular, and they have a darkish color and are tiny in size, which means they may be missed by manual analysis of ophthalmologists. In this case, accurate early detection of microaneurysms is helpful to cure DR before non-reversible blindness. In the proposed method, early detection of MAs is performed using a hybrid feature embedding approach of pre-trained CNN models, named as VGG-19 and Inception-v3. The performance of the proposed approach was evaluated using publicly available datasets, namely “E-Ophtha” and “DIARETDB1”, and achieved 96% and 94% classification accuracy, respectively. Furthermore, the developed approach outperformed the state-of-the-art approaches in terms of sensitivity and specificity for microaneurysms detection.


Sign in / Sign up

Export Citation Format

Share Document